1,799
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Chicoric acid advanced PAQR3 ubiquitination to ameliorate ferroptosis in diabetes nephropathy through the relieving of the interaction between PAQR3 and P110α pathway

, , , , ORCID Icon & ORCID Icon
Article: 2326021 | Received 25 Oct 2023, Accepted 26 Feb 2024, Published online: 25 Mar 2024

References

  • Guo F, Song Y, Wu L, Zhao Y, Ma X, Wang J, Shao M, Ji H, Huang F, Fan X, et al. SUMO specific peptidase 6 regulates the crosstalk between podocytes and glomerular endothelial cells in diabetic kidney disease. Biochim Biophys Acta Mol Bas Dis. 2023;1869(5):166685. doi:10.1016/j.bbadis.2023.166685.
  • Cook S, Schmedt N, Broughton J, Kalra PA, Tomlinson LA, Quint JK. Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the clinical practice research datalink. BMJ Open. 2023;13(3):e065927. doi:10.1136/bmjopen-2022-065927.
  • Buckley LF, Schmidt IM, Verma A, Palsson R, Adam D, Shah AM, Srivastava A, Waikar SS. Associations between kidney histopathologic lesions and incident cardiovascular disease in adults with chronic kidney disease. JAMA Cardiol. 2023;8(4):357. doi:10.1001/jamacardio.2023.0056.
  • Schmidt C. Confronting racial and ethnic disparities in diabetic kidney disease. Nature. 2023;615(7951):S8–14. doi:10.1038/d41586-023-00651-8.
  • Wang Y, Liu L, Ge M, Cui J, Dong X, Shao Y. Acacetin attenuates the pancreatic and hepatorenal dysfunction in type 2 diabetic rats induced by high-fat diet combined with streptozotocin. J Nat Med. 2023;77(3):446–454. doi:10.1007/s11418-022-01675-6.
  • Yin D, Guo Z, Zhang X. Identification of biomarkers and prediction of upstream miRnas in diabetic nephropathy. Front Endocrinol. 2023;14:1144331. doi:10.3389/fendo.2023.1144331.
  • Aleksandrov N, Audibert F, Bedard MJ, Mahone M, Goffinet F, Kadoch IJ. Gestational diabetes insipidus: a review of an underdiagnosed condition. J Obstetrics And Gynaecology Canada: JOGC = Journal d’obstetrique Et Gynecologie du Canada: JOGC. 2010;32(3):225–31. doi:10.1016/S1701-2163(16)34448-6.
  • Almalki MH, Ahmad MM, Brema I, Almehthel M, AlDahmani KM, Mahzari M, Beshyah SA. Management of diabetes insipidus following surgery for pituitary and suprasellar tumours. Sultan Qaboos Univ Med J. 2021;21(3):354–64. doi:10.18295/squmj.4.2021.010.
  • Lv S, Li H, Zhang T, Su X, Sun W, Wang Q, Wang L, Feng N, Zhang S, Wang Y, et al. San-Huang-Yi-Shen capsule ameliorates diabetic nephropathy in mice through inhibiting ferroptosis. Biomed Pharmacother Biomed Pharmacotherapie. 2023;165:115086.
  • Wei M, Liu X, Tan Z, Tian X, Li M, Wei J. Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy. Front Endocrinol. 2023;14:1188003. doi:10.3389/fendo.2023.1188003.
  • Zhang S, Li Y, Liu X, Guo S, Jiang L, Huang Y, Wu Y. Carnosine alleviates kidney tubular epithelial injury by targeting NRF2 mediated ferroptosis in diabetic nephropathy. Amino Acids. 2023;55(9):1141–55. doi:10.1007/s00726-023-03301-5.
  • Ma J, Li C, Liu T, Zhang L, Wen X, Liu X, Fan W. Identification of markers for diagnosis and treatment of diabetic kidney disease based on the ferroptosis and immune. Oxid Med Cell Longev. 2022;2022:1–21. doi:10.1155/2022/9957172.
  • Wang YH, Chang DY, Zhao MH, Chen M, Zoratti M. Glutathione peroxidase 4 is a predictor of diabetic kidney disease progression in type 2 diabetes mellitus. Oxid Med Cell Longev. 2022;2022:1–10. doi:10.1155/2022/2948248.
  • Lu Q, Yang L, Xiao JJ, Liu Q, Ni L, Hu JW, Yu H, Wu X, Zhang B-F. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway. Free Radical Biol Med. 2023;195:89–102. doi:10.1016/j.freeradbiomed.2022.12.088.
  • Pu Z, Shen C, Zhang W, Xie H, Wang W. Avenanthramide C from oats protects pyroptosis through dependent ROS-Induced mitochondrial damage by PI3K ubiquitination and phosphorylation in pediatric pneumonia. J Agric Food Chem. 2022;70(7):2339–53. doi:10.1021/acs.jafc.1c06223.
  • Zhang W, Wang W, Xu M, Xie H, Pu Z. GPR43 regulation of mitochondrial damage to alleviate inflammatory reaction in sepsis. Aging. 2021;13(18):22588–610. doi:10.18632/aging.203572.
  • Liu Y, Chou FJ, Lang F, Zhang M, Song H, Zhang W, Davis DL, Briceno NJ, Zhang Y, Cimino PJ, et al. Protein kinase B (PKB/AKT) protects IDH-mutated glioma from ferroptosis via Nrf2. Clin Cancer Res. 2023;29(7):1305–1316.
  • Cheng Y, Gao Y, Li J, Rui T, Li Q, Chen H, Jia B, Song Y, Gu Z, Wang T, et al. TrkB agonist N-acetyl serotonin promotes functional recovery after traumatic brain injury by suppressing ferroptosis via the PI3K/Akt/Nrf2/Ferritin H pathway. Free Radical Biol Med. 2023;194:184–98.
  • Yang H, Fang X, Shen Y, Yao W, Chen D, Shen L. MiR-153-3p reduces extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via targeting PAQR3 in diabetic nephropathy. Endocrinologia, diabetes y nutricion. 2022;69(1):34–42. doi:10.1016/j.endinu.2021.03.005.
  • Qiao S, Yang D, Li X, Li W, Zhang Y, Liu W. Silencing PAQR3 protects against oxygen-glucose deprivation/reperfusion-induced neuronal apoptosis via activation of PI3K/AKT signaling in PC12 cells. Life Sci. 2021;265:118806. doi:10.1016/j.lfs.2020.118806.
  • Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H. Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism. Acta Pharm Sin B. 2022;12(6):2887–904. doi:10.1016/j.apsb.2021.12.023.
  • Li X, Li M, Chen D, Shi G, Zhao H. PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer. Arch Med Sci. 2018;14(6):1289–97. doi:10.5114/aoms.2017.72220.
  • Tian L, Fu P, Zhou M, Qi J. Dandelion sterol improves diabetes mellitus-induced renal injury in in vitro and in vivo study. Food Sci Nutr. 2021;9(9):5183–97. doi:10.1002/fsn3.2491.
  • Liu XJ, Hu XK, Yang H, Gui LM, Cai ZX, Qi MS, Dai C-M. A review of traditional Chinese medicine on treatment of diabetic nephropathy and the involved mechanisms. Am J Chin Med. 2022;50(7):1739–79. doi:10.1142/S0192415X22500744.
  • Zhang L, Miao R, Yu T, Wei R, Tian F, Huang Y, Tong X, Zhao L. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: a systematic review and network meta-analysis. Pharmacol Res. 2022;177:106111. doi:10.1016/j.phrs.2022.106111.
  • Jabłońska-Trypuć A, Krętowski R, Świderski G, Cechowska-Pasko M, Lewandowski W. Cichoric acid attenuates the toxicity of mesotrione. Effect on in vitro skin cell model. Environ Toxicol Pharmacol. 2020;77:103375. doi:10.1016/j.etap.2020.103375.
  • Lai TW, Cheng HL, Su TR, Yang JJ, Su CC. Cichoric acid May play a role in protecting hair cells from ototoxic drugs. Int J Mol Sci. 2022;23(12):6701. doi:10.3390/ijms23126701.
  • Wang Q, Lin B, Li Z, Su J, Feng Y, Gu J. Cichoric acid ameliorates monosodium urate-induced inflammatory response by reducing NLRP3 inflammasome activation via inhibition of NF-kB signaling pathway. Evidence-based complementary and alternative medicine: eCAM 2021. Evid Based Complementary Altern Med. 2021;2021:1–12. doi:10.1155/2021/8868527.
  • Luo Z, Gao G, Ma Z, Liu Q, Gao X, Tang X, Gao Z, Li C, Sun T. Cichoric acid from witloof inhibit misfolding aggregation and fibrillation of hIAPP. Int J Biol Macromol. 2020;148:1272–79. doi:10.1016/j.ijbiomac.2019.10.100.
  • Ding X, Jian T, Li J, Lv H, Tong B, Li J, Meng X, Ren B, Chen J. Chicoric acid ameliorates nonalcoholic fatty liver disease via the AMPK/Nrf2/NFκB signaling pathway and restores gut microbiota in high-fat-diet-fed mice. Oxid Med Cell Longev. 2020;2020:1–20.
  • Kim M, Yoo G, Randy A, Kim HS, Nho CW. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. Mol Nutr Food Res. 2017;61(5). doi:10.1002/mnfr.201600632.
  • Pu Z, Sui B, Wang X, Wang W, Li L, Xie H. The effects and mechanisms of the anti-COVID-19 traditional Chinese medicine, dehydroandrographolide from andrographis paniculata (Burm.F.) wall, on acute lung injury by the inhibition of NLRP3-mediated pyroptosis. Phytomed: Inter J Phytothera And Phytopharmacol. 2023;114:154753. doi:10.1016/j.phymed.2023.154753.
  • Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H. Gentiopicroside targets PAQR3 to activate PI3K/AKT signaling pathway and ameliorate glucose and lipid metabolism. Acta Pharm Sin B. 2022;12(6):2887–904. doi:10.1016/j.apsb.2021.12.023.
  • Kim DL, Lee SE, Kim NH. Renal protection of mineralocorticoid receptor antagonist, finerenone, in diabetic kidney disease. Endocrinology And Metabolism (Seoul, Korea). 2023;38(1):43–55. doi:10.3803/EnM.2022.1629.
  • Liu MC, Li JL, Wang YF, Meng Y, Cai Z, Shen C, Wang M-D, Zhao W-J, Niu W-Q. Association between thyroid hormones and diabetic kidney disease in Chinese adults. BMC Endocr Disord. 2023;23(1):56. doi:10.1186/s12902-023-01299-1.
  • Wang X, Li Q, Sui B, Xu M, Pu Z, Qiu T, Zhang Z. Schisandrin a from Schisandra chinensis attenuates ferroptosis and NLRP3 inflammasome-mediated pyroptosis in diabetic nephropathy through mitochondrial damage by AdipoR1 ubiquitination. Oxid Med Cell Longev. 2022;2022:1–23. doi:10.1155/2022/5411462.
  • Schlernitzauer A, Oiry C, Hamad R, Galas S, Cortade F, Chabi B, Casas F, Pessemesse L, Fouret G, Feillet-Coudray C, et al. Chicoric acid is an antioxidant molecule that stimulates AMP kinase pathway in L6 myotubes and extends lifespan in caenorhabditis elegans. PLoS One. 2013;8(11):e78788. doi:10.1371/journal.pone.0078788.
  • Lee NY, Chung KS, Jin JS, Bang KS, Eom YJ, Hong CH, Nugroho A, Park H-J, An H-J. Effect of chicoric acid on mast cell-mediated allergic inflammation in vitro and in vivo. J Nat Prod. 2015;78(12):2956–62. doi:10.1021/acs.jnatprod.5b00668.
  • Ding XQ, Jian TY, Gai YN, Niu GT, Liu Y, Meng XH, Li J, Lyu H, Ren B-R, Chen J, et al. Chicoric acid attenuated renal tubular injury in HFD-Induced chronic kidney disease mice through the promotion of mitophagy via the Nrf2/PINK/Parkin pathway. J Agric Food Chem. 2022;70(9):2923–35. doi:10.1021/acs.jafc.1c07795.
  • Wu Y, Chen Y. Research progress on ferroptosis in diabetic kidney disease. Front Endocrinol. 2022;13:945976. doi:10.3389/fendo.2022.945976.
  • Wu Z, Li D, Tian D, Liu X, Wu Z, Gomes AV. Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition. PLoS One. 2022;17(12):e0279010. doi:10.1371/journal.pone.0279010.
  • Wang K, Gao S, Wang J, Yu F, Ye C. Protective effects of chicoric acid on LPS-induced endometritis in mice via inhibiting ferroptosis by Nrf2/HO-1 signal axis. Int Immunopharmacol. 2022;113(Pt B):109435. doi:10.1016/j.intimp.2022.109435.
  • Wang Y, Bi R, Quan F, Cao Q, Lin Y, Yue C, Cui X, Yang H, Gao X, Zhang D, et al. Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur J Pharmacol. 2020;888:173574.
  • Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radical Biol Med. 2021;162:435–49. doi:10.1016/j.freeradbiomed.2020.10.323.
  • Tan H, Chen J, Li Y, Li Y, Zhong Y, Li G, Liu L, Li Y. Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways. Mol Med. 2022;28(1):58. doi:10.1186/s10020-022-00481-w.
  • Ghaffari-Nasab A, Ghiasi F, Keyhanmanesh R, Roshangar L, Salmani Korjan E, Nazarpoor N, Mirzaei Bavil F. Bone marrow-derived c-kit positive stem cell administration protects against diabetes-induced nephropathy in a rat model by reversing PI3K/AKT/GSK-3β pathway and inhibiting cell apoptosis. Mol Cell Biochem. 2023. doi:10.1007/s11010-023-04750-y.
  • Kong Z, Xiao M, Wang B, Zhang W, Che K, Lv W, Wang Y, Huang Y, Zhao H, Zhao Y, et al. Renoprotective effect of isoorientin in diabetic nephropathy via activating autophagy and inhibiting the PI3K-AKT-TSC2-mTOR Pathway. Am J Chin Med. 2023;51(5):1269–91. doi:10.1142/S0192415X23500581.
  • Zhao T, Xiang Q, Lie B, Chen D, Li M, Zhang X, Yang J, He B, Zhang W, Dong R, et al. Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways. Heliyon. 2023;9(3):e14171. doi:10.1016/j.heliyon.2023.e14171.
  • Ding H, Ci X, Cheng H, Yu Q, Li D. Chicoric acid alleviates lipopolysaccharide-induced acute lung injury in mice through anti-inflammatory and anti-oxidant activities. Int Immunopharmacol. 2019;66:169–76. doi:10.1016/j.intimp.2018.10.042.